Detalles de la búsqueda
1.
Antiviral Activity of Oral JNJ-53718678 in Healthy Adult Volunteers Challenged With Respiratory Syncytial Virus: A Placebo-Controlled Study.
J Infect Dis
; 218(5): 748-756, 2018 07 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-29684148
2.
Virology analysis in HCV genotype 1-infected patients treated with the combination of simeprevir and TMC647055/ritonavir, with and without ribavirin, and JNJ-56914845.
Virol J
; 14(1): 101, 2017 05 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-28569206
3.
Efficacy, safety and pharmacokinetics of simeprevir and TMC647055/ritonavir with or without ribavirin and JNJ-56914845 in HCV genotype 1 infection.
BMC Gastroenterol
; 17(1): 26, 2017 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28187751
4.
Efficacy of re-treatment with TMC435 as combination therapy in hepatitis C virus-infected patients following TMC435 monotherapy.
Gastroenterology
; 143(5): 1176-1178.e6, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22885330
5.
Rapid HCV-RNA decline with once daily TMC435: a phase I study in healthy volunteers and hepatitis C patients.
Gastroenterology
; 138(3): 913-21, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19852962
6.
PrEP-001 prophylactic effect against rhinovirus and influenza virus - RESULTS of 2 randomized trials.
Antiviral Res
; 153: 70-77, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29567461
7.
Population Pharmacokinetic Modeling of JNJ-53718678, a Novel Fusion Inhibitor for the Treatment of Respiratory Syncytial Virus: Results from a Phase I, Double-Blind, Randomized, Placebo-Controlled First-in-Human Study in Healthy Adult Subjects.
Clin Pharmacokinet
; 56(11): 1331-1342, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28238203
8.
Evaluation of the Pharmacokinetics and Renal Excretion of Simeprevir in Subjects with Renal Impairment.
Drugs R D
; 15(3): 261-70, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26248593
9.
Antiviral Activity of TMC353121, a Respiratory Syncytial Virus (RSV) Fusion Inhibitor, in a Non-Human Primate Model.
PLoS One
; 10(5): e0126959, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26010881
10.
Safety and pharmacokinetics of the HIV-1 protease inhibitor TMC310911 coadministered with ritonavir in healthy participants: results from 2 phase 1 studies.
J Acquir Immune Defic Syndr
; 65(3): 299-305, 2014 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24121757
11.
Antiviral activity, pharmacokinetics, and safety of the HIV-1 protease inhibitor TMC310911, coadministered with ritonavir, in treatment-naive HIV-1-infected patients.
J Acquir Immune Defic Syndr
; 65(3): 283-9, 2014 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24121756
12.
In vivo evaluation of antiviral compounds on respiratory syncytial virus using a juvenile vervet monkey (Chlorocebus pygerythrus) infection model.
Methods Mol Biol
; 1030: 373-82, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23821283
13.
Rapid viral response of once-daily TMC435 plus pegylated interferon/ribavirin in hepatitis C genotype-1 patients: a randomized trial.
Antivir Ther
; 16(7): 1021-33, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22024518
Resultados
1 -
13
de 13
1
Próxima >
>>